1. Home
  2. FAMI vs AIDX Comparison

FAMI vs AIDX Comparison

Compare FAMI & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmmi Inc.

FAMI

Farmmi Inc.

HOLD

Current Price

$0.12

Market Cap

4.6M

ML Signal

HOLD

Logo 20/20 Biolabs Inc. Common Stock

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$0.35

Market Cap

4.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FAMI
AIDX
Founded
2015
2000
Country
China
United States
Employees
N/A
N/A
Industry
Packaged Foods
Precision Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
4.9M
IPO Year
2017
2025

Fundamental Metrics

Financial Performance
Metric
FAMI
AIDX
Price
$0.12
$0.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 18.7M
43.9K
Earning Date
08-27-2026
11-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 34.48
EPS
★ N/A
N/A
Revenue
N/A
★ $2,045,133.00
Revenue This Year
N/A
$44.20
Revenue Next Year
N/A
$95.73
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 16.71
52 Week Low
$0.09
$0.33
52 Week High
$1.97
$14.09

Technical Indicators

Market Signals
Indicator
FAMI
AIDX
Relative Strength Index (RSI) 44.30 28.15
Support Level $0.10 N/A
Resistance Level $0.20 $0.49
Average True Range (ATR) 0.02 0.04
MACD 0.00 -0.01
Stochastic Oscillator 10.09 12.69

Price Performance

Historical Comparison
FAMI
AIDX

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe and the Middle East under the Forasen and Farmmi brands.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: